Showing 4,221 - 4,240 results of 24,535 for search 'LiveAD~', query time: 5.60s Refine Results
  1. 4221

    Liver Biomarkers and Lipid Profiles in Mexican and Mexican-American 10- to 14-Year-Old Adolescents at Risk for Type 2 Diabetes by Ana Cecilia Fernández-Gaxiola, Roxana Valdés-Ramos, Kimberly Fulda, Ana Laura Guadarrama López, Beatriz E. Martínez-Carrillo, Susan F. Franks, Shane Fernando

    Published 2017-01-01
    “…Liver enzymes alanine aminotransferase (ALT) and gamma glutamyl transferase (GGT) are markers for type 2 diabetes mellitus (T2DM); alkaline phosphatase is a marker of liver disease. …”
    Get full text
    Article
  2. 4222
  3. 4223

    Hepatoprotective Effects of Crude Stem Bark Extracts and Solvent Fractions of Cordia africana against Acetaminophen-Induced Liver Injury in Rats by Gudeta Duga Geresu, Shemsu Umer, Mahlet Arayaselassie, Genet Ashebir, Eyasu Makonnen

    Published 2022-01-01
    “…Cordia africana Lam (Boraginaceae) is widely used in Ethiopian folk medicine for the treatment of different types of liver disorders. Thus, this study aimed to investigate the hepatoprotective effects of an aqueous (CAAE), 80% methanol extracts of C. africana stem bark (CAME), and the solvent fractions of the methanol extract against acetaminophen (APAP)-induced liver injury in rats. …”
    Get full text
    Article
  4. 4224

    Novel Organic Mineral Complex Prevents High-Fat Diet-Induced Changes in the Gut and Liver of Male Sprague-Dawley Rats by M. S. Crawford, A. E. Mohr, K. L. Sweazea

    Published 2020-01-01
    “…The aim of this study was to further examine the effects of OMC on the liver and gastrointestinal health of these rats. …”
    Get full text
    Article
  5. 4225
  6. 4226
  7. 4227

    Genotype 3 is linked to worse liver disease progression in hepatitis C patients even after SVR following DAA therapy by Xiping Ran, Xiping Ran, Yang Xu, Ying Wang, Cheng Zeng, Chen Gong, Ni Wang, Dachuan Cai, Dachuan Cai

    Published 2025-02-01
    “…Background and aimsHCV genotype (GT) 3 is associated with rapid liver disease progression. However, the liver disease progression and its risk factors in patients with HCV GT 3 infection after sustained virological response (SVR) following direct-acting antivirals (DAAs) remain unclear. …”
    Get full text
    Article
  8. 4228

    Systematic review of the impact of non-alcoholic fatty liver disease on mortality and adverse clinical outcomes for individuals with chronic kidney disease by Paul Roderick, Julie Parkes, Theresa Hydes, Ryan Buchanan, Oliver J Kennedy, Simon Fraser

    Published 2020-09-01
    “…Objectives To investigate if non-alcoholic fatty liver disease (NAFLD) impacts mortality and adverse outcomes for individuals with chronic kidney disease (CKD).Design Systematic review.Data sources PubMed, EMBASE and Web of Science were searched up to 1 February 2020 with no restriction on the earliest date.Eligibility criteria for selecting studies Observational cohort studies that reported either the risk of all-cause mortality, incidence of non-fatal cardiovascular events (CVE) or progression of kidney disease among adults with established CKD who have NAFLD compared with those without.Data extraction and synthesis Two reviewers extracted data and assessed bias independently.Results Of 2604 records identified, 3 studies were included (UK (n=852), South Korea (n=1525) and USA (n=1413)). …”
    Get full text
    Article
  9. 4229
  10. 4230
  11. 4231

    Transcriptome Analyses Reveal Lipid Metabolic Process in Liver Related to the Difference of Carcass Fat Content in Rainbow Trout (Oncorhynchus mykiss) by Guo Hu, Wei Gu, Peng Sun, Qingli Bai, Bingqian Wang

    Published 2016-01-01
    “…Similar to farmed animals and humans, the liver can be considered one of the most important organs involved in lipid metabolism in rainbow trout (Oncorhynchus mykiss). …”
    Get full text
    Article
  12. 4232

    IL-1β Pretreatment Improves the Efficacy of Mesenchymal Stem Cells on Acute Liver Failure by Enhancing CXCR4 Expression by He Nie, Fangmei An, Jie Mei, Cheng Yang, Qiang Zhan, Qinglin Zhang

    Published 2020-01-01
    “…Mesenchymal stem cells (MSCs), with the powerful metabolic and functional supporting abilities for inflammatory diseases, may be an effective therapeutic strategy for acute liver failure (ALF). However, the efficacy of MSCs can still be promoted if pretreatment is applied to enhance their poor migration towards the damaged liver. …”
    Get full text
    Article
  13. 4233

    The Effect of Mesenchymal Stem Cell-Derived Exosomes and miR17-5p Inhibitor on Multicellular Liver Fibrosis Microtissues by Farnaz Sani, Mina Soufi Zomorrod, Negar Azarpira, Masoud Soleimani

    Published 2023-01-01
    “…Although several studies have been conducted on modeling human liver disease, it is still challenging to mimic nonalcoholic fatty liver disease in vitro. …”
    Get full text
    Article
  14. 4234
  15. 4235
  16. 4236

    Desarrollo de un dispositivo para monitoreo en la línea del proceso de coagulación de la leche by O.A. SBODIO, E.D.A. MARTÍNEZ, E.J. TERCERO, M.J.J. DIDIER, G.R. REVELLI

    Published 2017-01-01
    “…Cumple con las normas sanitarias 3-A y EHEDG, lo cual permite que sea usado tanto en las líneas de producción de queso como de yogurt.…”
    Get full text
    Article
  17. 4237
  18. 4238
  19. 4239

    Hepatocellular Carcinoma: Consensus, Controversies and Future Directions: A Report from the Canadian Association for the Study of the Liver Hepatocellular Carcinoma Meeting by Kelly Warren Burak, Morris Sherman

    Published 2015-01-01
    “…Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide and its incidence has rapidly increased in North America in recent years. …”
    Get full text
    Article
  20. 4240

    Effects of Metabolism-Related Indicators on Nonalcoholic Fatty Liver Disease in Nonobese Population Based on the National Health and Nutrition Examination Survey by XingWang Zhu, HaiPing Wang, HongLong Zhang, Guole Nie, Jun Yan, Xun Li

    Published 2024-01-01
    “…Objective. Nonalcoholic fatty liver disease (NAFLD) is becoming more prevalent in the nonobese population. …”
    Get full text
    Article